Keywords: roche, wins, first, approval, xeloda, colorectal, cancer

Roche wins first approval for Xeloda in colorectal cancer

Article | 20 June 2000

Print This

Hoffmann-La Roche has received its first approval, from the New ZealandMinistry of Health, to market its oral chemotherapy agent Xeloda ( ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in